enzalutamide,talazoparib,abiraterone,olaparib,niraparib
astellas,pfizer,Merck,AstraZeneca,janssen
['prostate']
parp inhibitors trials in prostate cancer .
to give upfront or sequential is the question. #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists